117 related articles for article (PubMed ID: 21360536)
1. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.
Sellner F; Thalhammer S; Stättner S; Karner J; Klimpfinger M
J Surg Oncol; 2011 Jul; 104(1):17-21. PubMed ID: 21360536
[TBL] [Abstract][Full Text] [Related]
2. Support for a postresection prognostic score for pancreatic endocrine tumors.
Hurtuk MG; Godambe AS; Shoup M; Yong S; Aranha GV
Am J Surg; 2011 Mar; 201(3):406-10; discussion 410. PubMed ID: 21367388
[TBL] [Abstract][Full Text] [Related]
3. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
[TBL] [Abstract][Full Text] [Related]
4. [Early diagnosis of pancreatic cancer is essential to improving the effect of treatment].
Zheng SS; Huang DS; Li QY; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Xu X; Yu J
Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):322-3. PubMed ID: 12892581
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior.
Boninsegna L; Partelli S; D'Innocenzio MM; Capelli P; Scarpa A; Bassi C; Pederzoli P; Falconi M
Neuroendocrinology; 2010; 92(4):246-51. PubMed ID: 20689265
[TBL] [Abstract][Full Text] [Related]
6. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
Nissen NN; Kim AS; Yu R; Wolin EM; Friedman ML; Lo SK; Wachsman AM; Colquhoun SD
Am Surg; 2009 Oct; 75(10):1025-9. PubMed ID: 19886158
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
9. Proposed histopathologic grading system derived from a study of KIT and CK19 expression in pancreatic endocrine neoplasm.
Zhang L; Lohse CM; Dao LN; Smyrk TC
Hum Pathol; 2011 Mar; 42(3):324-31. PubMed ID: 21190722
[TBL] [Abstract][Full Text] [Related]
10. [Pancreatic endocrine tumors].
Kochatkov AV; Kriger AG; Gorin DS; Lebedeva AN
Khirurgiia (Mosk); 2010; (9):71-80. PubMed ID: 21513034
[No Abstract] [Full Text] [Related]
11. [Effect of tumor size and lymph node status on the prognosis of pancreatic cancer].
Bittner R; Roscher R; Safi F; Dopfer HP; Schölzel E; Beger HG
Chirurg; 1989 Apr; 60(4):240-5. PubMed ID: 2541980
[TBL] [Abstract][Full Text] [Related]
12. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
Vagefi PA; Razo O; Deshpande V; McGrath DJ; Lauwers GY; Thayer SP; Warshaw AL; Fernández-Del Castillo C
Arch Surg; 2007 Apr; 142(4):347-54. PubMed ID: 17438169
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
[TBL] [Abstract][Full Text] [Related]
14. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
15. Resection of a non-functioning islet cell carcinoma occupying the entire pancreas.
Murase J; Kubo S; Hirohashi K; Shuto T; Tanaka H; Hamba H; Kinoshita H; Ikebe T; Wakasa K
Hepatogastroenterology; 2000; 47(34):1168-9. PubMed ID: 11020906
[TBL] [Abstract][Full Text] [Related]
16. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
[TBL] [Abstract][Full Text] [Related]
17. Central pancreatectomy: single-center experience of 50 cases.
Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features, diagnosis and treatment of 38 neuroendocrine carcinoma in the digestive system].
Chen CQ; Chen HL; Cai SR; Wang Z; Ma JP; Zhang CH; He YL
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Aug; 13(8):587-9. PubMed ID: 20737310
[TBL] [Abstract][Full Text] [Related]
20. Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases.
Goh BK; Chow PK; Tan YM; Cheow PC; Chung YF; Soo KC; Wong WK; Ooi LL
ANZ J Surg; 2011 Jan; 81(1-2):79-85. PubMed ID: 21299804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
